The receptor binding domain (RBD) on the S1 subunit of the spike protein is a known target for neutralising antibodies (NAb), which play a key role in infection prevention and viral clearance due to the role spike-RBD-ACE2 binding plays in SARS-CoV-2 entry into cells (6). Here, ACE2 is linked to infection.